Zimbabwe has declined a significant American healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to Washington's insistence on sensitive information.
This move was revealed following a internal memorandum from December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".
A government spokesperson has since explained that the United States was seeking health data for scientific study and profit while was not willing to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable task of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had furnished more than $1.9bn in health funding to Zimbabwe over the last twenty years.
A medical body in Zimbabwe has called for continued negotiations to secure a deal agreeable to all parties so the nation's vital HIV programme can proceed.
Broader Implications
This development comes after a comparable case in neighbouring Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has reduced foreign aid and closed the US Agency for International Development (USAID).
USAID had administered aid for the US government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
Based on statements, Sixteen African countries have so far agreed to similar agreements, constituting more than $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation might have yielded immense advantages for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment through US-supported programmes," the Ambassador added.
However, official spokesman Nick Mangwana argued the arrangement was "unequal".
"The proposal required Zimbabwe to surrender its biological resources and data indefinitely, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might result from that shared data," he stated.
"Effectively, our country would supply the raw materials for medical research without any assurance that the resulting innovations would be accessible to our population if a new disease outbreak arise."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting systems already set up through the global organization.
The spokesperson cited its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This system is designed to ensure that when a country contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised solely by those with the funds to create them."
These objections regarding the US deal "are not meant as opposition to America," he added.
"We are open to continued dialogue with our American counterparts on how subsequent collaboration could be structured in a way that honours the sovereignty and interests of each country."
Health Experts Reaction
Medical experts said it understood the official position, but suggested that negotiations must proceed given that a large portion of the country's HIV programmes relied on foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it said.
This impasse highlights the ongoing tensions between accepting crucial international aid and safeguarding a country's data in an ever more interconnected world.